30 Dec 2024 Precigen ActoBio Announces Additional Positive Interim Data from Phase 1b/2a Study of AG019 ActoBiotics™, A Novel Therapy Designed to Address the Underlying Cause of Type 1 Diabetes Member news
21 Nov 2024 Bio Base Europe Pilot Plant successfully commissions a 75,000 L fermenter, demonstrating Vivici’s Vivitein™ BLG technology in industrial-scale precision fermentation Member news
08 Oct 2024 UZ Leuven and KU Leuven invest 14 million euro in new cell and gene therapy facility Member news
27 Jun 2024 Biotech company SwiftPharma receives capital injection to achieve ambitious growth Member news
16 Jan 2024 Health & care incubator BioVille strengthens its position with additional 2,000m² wing Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
